ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 732737 Null 0.0297837393005856 0.16885951
NSC 733891 arypurine derivatives 0.0297837393005856 0.074550352
NSC 742554 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, 0.0297837393005856 0.26626238
NSC 747459 Null 0.0297837393005856 0.43038873
NSC 748643 Mitaplatin 0.0297837393005856 0.6559822
NSC 665549 Azoxydapsone {1,2-bis-[4-(4'-aminophenylsulfonylphenyl)]- diazine-1-oxide} 0.0321614375606954 -0.15902846
NSC 135168 Null 0.0348927754043159 0.20300902
NSC 142587 Null 0.0348927754043159 0.18686969
NSC 267319 Null 0.0348927754043159 0.079106792
NSC 3080 s-Triazine, 4,6-diamino-1-(m-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0348927754043159 0.30662514
Total:90  Current:62    [First] [Prev] [Next] [Last]